Mark Ballow

10.1k total citations · 1 hit paper
195 papers, 6.5k citations indexed

About

Mark Ballow is a scholar working on Immunology, Hematology and Genetics. According to data from OpenAlex, Mark Ballow has authored 195 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 132 papers in Immunology, 45 papers in Hematology and 39 papers in Genetics. Recurrent topics in Mark Ballow's work include Immunodeficiency and Autoimmune Disorders (88 papers), Platelet Disorders and Treatments (30 papers) and Blood disorders and treatments (23 papers). Mark Ballow is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (88 papers), Platelet Disorders and Treatments (30 papers) and Blood disorders and treatments (23 papers). Mark Ballow collaborates with scholars based in United States, Canada and Sweden. Mark Ballow's co-authors include Charles G. Cochrane, Jordan S. Orange, Javier Chinen, Francisco A. Bonilla, William B. White, Elham Hossny, Yehia El‐Gamal, Bruce Mazer, Cheryl Allen and Peter C. Donshik and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Mark Ballow

188 papers receiving 6.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Update on the use of immunoglobulin in human disease: A review of evidence

2016 423 citations Jordan S. Orange, Javier Chinen et al. Journal of Allergy and Clinical Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Ballow United States	42	3.4k	1.4k	1.1k	1.1k	879	195	6.5k
Morton J. Cowan United States	42	2.4k 0.7×	1.4k 1.0×	1.1k 1.1×	1.2k 1.1×	777 0.9×	204	5.9k
E. Richard Stiehm United States	47	4.5k 1.3×	1.3k 0.9×	2.2k 2.1×	1.3k 1.3×	1.0k 1.1×	184	9.3k
Marjatta Leirisalo‐Repo Finland	52	2.6k 0.8×	2.4k 1.7×	722 0.7×	716 0.7×	378 0.4×	296	9.9k
Thomas A. Fleisher United States	53	5.6k 1.6×	1.0k 0.7×	1.0k 1.0×	1.0k 1.0×	557 0.6×	163	8.1k
Toshiro Hara Japan	46	3.3k 1.0×	1.6k 1.1×	1.4k 1.3×	1.2k 1.2×	1.5k 1.7×	432	9.7k
W. Conrad Liles United States	52	2.9k 0.8×	1.3k 0.9×	1.6k 1.5×	1.1k 1.0×	1.6k 1.8×	158	9.9k
Peter H. Schur United States	62	6.5k 1.9×	2.3k 1.6×	1.5k 1.4×	922 0.9×	825 0.9×	224	14.3k
Reinhard Seger Switzerland	43	4.8k 1.4×	1.0k 0.7×	1.4k 1.3×	1.6k 1.5×	660 0.8×	141	7.8k
Edmond J. Yunis United States	55	5.6k 1.6×	1.3k 0.9×	1.7k 1.6×	1.5k 1.4×	359 0.4×	346	10.9k
Anthony G. Wilson United Kingdom	44	2.6k 0.8×	666 0.5×	1.2k 1.2×	758 0.7×	409 0.5×	90	7.1k

Countries citing papers authored by Mark Ballow

Since Specialization

Citations

This map shows the geographic impact of Mark Ballow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Ballow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Ballow more than expected).

Fields of papers citing papers by Mark Ballow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Ballow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Ballow. The network helps show where Mark Ballow may publish in the future.

Co-authorship network of co-authors of Mark Ballow

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Ballow. A scholar is included among the top collaborators of Mark Ballow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Ballow. Mark Ballow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Otani, Iris M. & Mark Ballow. (2024). If and When to Consider Prophylactic Immunoglobulin Replacement Therapy in Secondary Hypogammaglobulinemia. The Journal of Allergy and Clinical Immunology In Practice. 13(3). 511–521.

Ballow, Mark, Silvia Sánchez‐Ramón, & Jolán E. Walter. (2022). Secondary Immune Deficiency and Primary Immune Deficiency Crossovers: Hematological Malignancies and Autoimmune Diseases. Frontiers in Immunology. 13. 928062–928062. 28 indexed citations

Ballow, Mark, et al.. (2020). Nuts and Bolts of Subcutaneous Therapy. Immunology and Allergy Clinics of North America. 40(3). 527–537. 4 indexed citations

Vogel, Beth, Michele Caggana, Vincent R. Bonagura, et al.. (2017). Idiopathic T cell lymphopenia identified in New York State Newborn Screening. Clinical Immunology. 183. 36–40. 24 indexed citations

Ballow, Mark, Mark R. Conaway, Rima Rachid, et al.. (2016). Construction and Validation of a Health-Related Quality of Life (HR-QOL) Instrument for Patients with Primary Antibody Deficiency Disease. Journal of Allergy and Clinical Immunology. 137(2). AB221–AB221. 1 indexed citations

Navarro, Robert, et al.. (2012). Considerations for the optimal use of immunoglobulin.. PubMed. 18(4 Suppl). S67–78. 13 indexed citations

Lee, Susan & Mark Ballow. (2010). Monoclonal antibodies and fusion proteins and their complications: Targeting B cells in autoimmune diseases. Journal of Allergy and Clinical Immunology. 125(4). 814–820. 29 indexed citations

Yong, Pierre L, John Boyle, Mark Ballow, et al.. (2009). Use of intravenous immunoglobulin and adjunctive therapies in the treatment of primary immunodeficiencies. Clinical Immunology. 135(2). 255–263. 78 indexed citations

Ballow, Mark. (2009). Clinical experience with Flebogamma® 5% DIF: a new generation of intravenous immunoglobulins in patients with primary immunodeficiency disease. Clinical & Experimental Immunology. 157(Supplement_1). 22–25. 7 indexed citations

10.

Ballow, Mark. (2008). Immunoglobulin therapy: Methods of delivery. Journal of Allergy and Clinical Immunology. 122(5). 1038–1039. 22 indexed citations

11.

Duffy, Linda C., et al.. (1999). Survey of Quality of Care for Asthmatic Children Seen in a Pediatric Emergency Room. Pediatric Asthma Allergy & Immunology. 13(2). 67–77. 2 indexed citations

12.

Bernstein, Joel M., et al.. (1997). The Microbial Ecology and Immunology of the Adenoid: Implications for Otitis Media. Annals of the New York Academy of Sciences. 830(1). 19–31. 18 indexed citations

13.

Markert, M. Louise, Donna D. Kostyu, Frances E. Ward, et al.. (1997). Successful formation of a chimeric human thymus allograft following transplantation of cultured postnatal human thymus. The Journal of Immunology. 158(2). 998–1005. 62 indexed citations

14.

Ballow, Mark, et al.. (1997). Hot Dog Vapor-Induced Status Asthmaticus. Annals of Allergy Asthma & Immunology. 78(1). 35–36. 12 indexed citations

15.

Ballow, Mark. (1991). Mechanisms of action of intravenous immunoglobulin therapy and potential use in autoimmune connective tissue diseases. Cancer. 68(S6). 1430–1436. 45 indexed citations

16.

Tedesco, J. L., et al.. (1988). Tear lysozyme and lactoferrin levels in giant papillary conjunctivitis and vernal conjunctivitis.. PubMed. 14(4). 207–9. 15 indexed citations

17.

White, William B., Charlene Desbonnet, & Mark Ballow. (1987). Immunoregulatory effects of intravenous immune serum globulin therapy in common variable hypogammaglobulinemia. The American Journal of Medicine. 83(3). 431–436. 31 indexed citations

18.

White, William B. & Mark Ballow. (1985). Modulation of Suppressor-Cell Activity by Cimetidine in Patients with Common Variable Hypogammaglobulinemia. New England Journal of Medicine. 312(4). 198–202. 107 indexed citations

19.

Ballow, Mark, G S Incefy, Robert A. Good, Savita Pahwa, & Martha L. Lepow. (1977). SEVERE COMBINED IMMUNODEFICIENCY WITH B LYMPHOCYTES, ANTIBODY SYNTHESIS AND RESPONSE TO ALLOGENEIC CELLS IN MLC. Pediatric Research. 11(4). 484–484. 3 indexed citations

20.

Ballow, Mark & Lawrence R. Hyman. (1977). Combination immunotherapy in chronic mucocutaneous candidiasis synergism between transfer factor and fetal thymus tissue. Clinical Immunology and Immunopathology. 8(3). 504–512. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact